The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis
批准号:
8528691
负责人:
Cory Michael Robinson
金额:
$22.67万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2014-08-30
关键词:
Antimycobacterial AgentsBacteriaBasic ScienceCellsChronicClinicalControlled StudyDeveloping CountriesDiseaseDisease OutcomeDrug resistanceDrug resistance in tuberculosisEffectivenessEnhancersEnvironmentEpidemicExhibitsExtreme drug resistant tuberculosisFrequenciesGene ExpressionGenesGenetic TranscriptionGrowthHIVHealthHumanImmune responseImmune systemImmunityImmunotherapeutic agentIn VitroIndividualInfectionInfection ControlInflammation MediatorsInterferonsInterleukin-12InterleukinsMediatingMetabolismMolecularMulti-Drug ResistanceMusMycobacterium InfectionsMycobacterium tuberculosisNatural ImmunityNitric OxideNucleic Acid Regulatory SequencesOrganellesOutcomePathway interactionsPhagosomesPharmacotherapyPlayPopulationPrevalenceProductionProteinsPublic HealthReagentRecoveryRegulatory ElementResearchRoleSeveritiesSignal TransductionTestingTherapeuticTuberculosisTumor Necrosis Factor-alphaVaccinesWorkadaptive immunityautocrinechemokinecombatcytokinedesignimprovedinsightinterestlatent infectionmacrophagemortalitymycobacterialnovelnovel strategiesparacrinepathogenpreventreceptorresistant strainresponsetraffickingvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Tuberculosis is a disease that rennains a nnajor thireat to global public health. The severity of the epidemic
has been intensified by the frequency of coinfection with HIV in developing nations and the emergence of
multidrug resistant strains. Novel approaches to stimulate a more protective immune response are of
particular interest to combat the increase in drug resistant strains. Our long-term objective is to understand
the involvement of interleukin (IL)-12 and IL-27 in human macrophage responses and the impact of these
responses on the complete immune response during tuberculosis. The major hypothesis to be investigated
in this proposal is that autocrine/paracrine response to IL-27 impedes macrophage effector functions that
control growth of M. tuberculosis. Oui- preliminary results have indicated that when IL-27 is neutralized
during infection of IL-12-treated macrophages, there is a significant reduction in mycobacterial recovery.
Consistent with control of mycobacterial growth is elevated production of interferon (IFN)-D and TNF-D by
infected macrophages treated with IL-12 and a soluble receptor to neutralize IL-27. The first aim utilizes
molecular approaches to identify important cytokines and test the hypothesis that tumor necrosis factor and
IFN-D are indispensable to this mechanism. The second specific aim investigates the consequences of IL-
12 treatment and neutralization of IL-27 on macrophage effector functions. The rationale involved is that
IFN-D produced as a result of this treatment promotes a toxic intracellular environment that hinders
mycobacterial growth. The work described in this aim investigates the involvement of nitric oxide in the
macrophage response during infection and examines progression ofthe mycobacterial phagosome within
the endosomal pathway. The third specific aim tests the hypothesis that novel mechanisms operate to
control transcription of IL-27 EBI3 and p28 genes. Since IL-27 is involved in host responses to a number of
chronic infections and disease states, including tuberculosis, it is important to understand the molecular
mechanisms that regulate IL-27 gene expression. We have proposed basic research into host immune
responses during infection that could have implications in design of therapeutic strategies and vaccines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis
-
批准号:10624257
-
项目类别:
-
资助金额:$46.4万
-
财政年份:2021
-
负责人:Cory Michael Robinson
-
依托单位:
Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis
-
批准号:10278311
-
项目类别:
-
资助金额:$50.96万
-
财政年份:2021
-
负责人:Cory Michael Robinson
-
依托单位:
Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis
-
批准号:10414998
-
项目类别:
-
资助金额:$49.44万
-
财政年份:2021
-
负责人:Cory Michael Robinson
-
依托单位:
The regulation of early life interleukin-27 expression and metabolic impact
-
批准号:10040906
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2020
-
负责人:Cory Michael Robinson
-
依托单位:
The regulation of early life interleukin-27 expression and metabolic impact
-
批准号:10171779
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2020
-
负责人:Cory Michael Robinson
-
依托单位:
Cellular expression and regulation of interleukin-27 in the neonatal immune syste
-
批准号:8978385
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2014
-
负责人:Cory Michael Robinson
-
依托单位:
Cellular expression and regulation of interleukin-27 in the neonatal immune syste
-
批准号:8890783
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2014
-
负责人:Cory Michael Robinson
-
依托单位:
Cellular expression and regulation of interleukin-27 in the neonatal immune syste
-
批准号:8753444
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2014
-
负责人:Cory Michael Robinson
-
依托单位:
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis
-
批准号:8293126
-
项目类别:
-
资助金额:$24.28万
-
财政年份:2011
-
负责人:Cory Michael Robinson
-
依托单位:
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis
-
批准号:8166093
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:Cory Michael Robinson
-
依托单位:
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis
-
批准号:7662609
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2009
-
负责人:Cory Michael Robinson
-
依托单位:
国内基金
海外基金
Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
-
批准号:81971557
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2019
-
负责人:毛开睿
-
依托单位:
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制
-
批准号:51678163
-
项目类别:面上项目
-
资助金额:64.0万元
-
批准年份:2016
-
负责人:许玫英
-
依托单位: